Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products.
Lipid peroxidation due to oxidative stress is accelerated under hyperglycemic conditions such as diabetes mellitus. The effect of 4-hydroxy-2-nonenal (HNE) and other lipid peroxidation products on the ability of isolated rat pancreatic islets to secrete insulin was examined in this study. HNE concentration- and time-dependently deteriorated glucose-induced insulin secretion: insulin secretion was decreased by 50% when measured after incubation of islets with 100 microM HNE for 1 h. Other lipid peroxidation products, e.g. 2-hexenal and 2-butenal, also inhibited glucose-induced insulin secretion. HNE at 100 microM lowered alpha-ketoisocaproate-induced insulin secretion, whereas leucine-induced insulin secretion was stimulated. Insulin secretion induced by 10 mM glyceraldehyde was slightly decreased by HNE. On the other hand, HNE severely decreased insulin secretion induced by 10 mM glyceraldehyde and 2.8 mM glucose. Glucose utilization and glucose oxidation were significantly lowered in islets treated with HNE. The amounts of fructose 1,6-bisphosphate and dihydroxyacetone phosphate in islets were decreased by treatment with HNE, whereas the amount of fructose 6-phosphate was increased. Our study indicates that HNE and other lipid peroxidation products impair insulin secretion induced by glucose probably through affecting both the glycolytic pathway and the citric acid cycle.
Department of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan. miwaichi@meijo-u.ac.jp
I
I
Miwa
N
N
Ichimura
M
M
Sugiura
Y
Y
Hamada
S
S
Taniguchi
D000447:Aldehydes / Q000494:pharmacology*; D000818:Animals; D002952:Citric Acid Cycle / Q000187:drug effects; D004099:Dihydroxyacetone Phosphate / Q000378:metabolism; D005260:Female; D005635:Fructosediphosphates / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology*; D005985:Glyceraldehyde / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D007651:Keto Acids / Q000494:pharmacology; D007930:Leucine / Q000494:pharmacology; D015227:Lipid Peroxidation; D018384:Oxidative Stress; D051381:Rats; D017208:Rats, Wistar
D000447:Aldehydes; D005635:Fructosediphosphates; D007328:Insulin; D007651:Keto Acids; D005985:Glyceraldehyde; C051750:2-hexenal; D004099:Dihydroxyacetone Phosphate; C013082:alpha-ketoisocaproic acid; C012796:2-butenal; D007930:Leucine; D005947:Glucose; C027576:4-hydroxy-2-nonenal; C029063:fructose-1,6-diphosphate